Pharmacokinetics of Saquinavir, Atazanavir, and Ritonavir in a Twice-Daily Boosted Double-Protease Inhibitor Regimen

The objective of this study was to evaluate the pharmacokinetics of atazanavir (ATV), saquinavir (SQV), and ritonavir (RTV) in a boosted double-protease inhibitor (PI) therapy regimen without reverse transcriptase inhibitors (RTIs). The study design was as follows. Patients with limited RTI options...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: von Hentig, Nils, Müller, Axel, Rottmann, Carsten, Wolf, Timo, Lutz, Thomas, Klauke, Stephan, Kurowski, Michael, Oertel, Bruno, Dauer, Brenda, Harder, Sebastian, Staszewski, Schlomo
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2007
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1855477/
https://ncbi.nlm.nih.gov/pubmed/17296738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00854-06
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items